Clinical Trial Update: A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Tobemstomig plus platinum-based chemotherapy against Pembrolizumab plus platinum-based chemotherapy in previously untreated non-small ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Tobemstomig

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-11-19